Fund moves

CME Group (CME)PineStone Asset Management Inc. added to its stake +125K shares

PineStone Asset Management Inc. added to its stake in CME Group, per its Q2 2026 13F.

2.72M
Shares reported · +125K vs prior quarter
3.7%
Disclosed portfolio weight
$601M
Reported value
Holdings as of
Jun 30, 2026
Filed
Jul 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  2. May 15, 2026Insider · 1 personInsiders: 2 sales (~$10.4M)
  3. May 18, 2026Insider · Their largest sale since 2007Officer sold ~$1.75M of CME shares in the open market
  4. Jun 12, 2026Government · Federal Register proposed rulePrediction Markets; Public Interest Determinations
  5. Jun 16, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 17, 2026, CME Group Inc. (the “Company”) announced that Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman, and Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive Officer (the “Leadership Transition”).”
  6. Jun 16, 2026CongressDisclosed partial sale of CME — reported range $1,001 - $15,000

What came next

  1. Jul 15, 2026Government · Federal Register noticeOrder Under Section 36 of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 6h-1(d) Thereunder Granting Conditional Exemptive Relief to the Chicago Mercantile Exchange Inc. From the Opening Price Settlement Requirements of Rule 6h-1(b) Under the Exchange Act for Certain Cash-Settled Security Futures
  2. Jul 22, 2026Company filing · Form 8-K · ResultsReported its results
  3. Aug 3, 2026Government · Federal Register noticeIn the Matter of Nasdaq PHLX LLC; Order Granting Petition for Review and Scheduling Filing of Statements Regarding an Order Approving, on an Accelerated Basis, a Proposed Rule Change, as Modified by Amendment No. 1, To List and Trade Nasdaq Bitcoin Index Options
  4. Aug 6, 2026Government · Federal Register proposed ruleConflicts and Affiliations
  5. Sep 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“As described in the attached press release, CME Group Inc. (“CME Group” or the “Company”) announced new senior leadership appointments in its finance and legal divisions.”
  6. Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
  7. Sep 14, 2026InsiderDirector sold ~$140K of CME shares in the open market
  8. Sep 24, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for CME Group

For CME Group, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 60 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

How this filing works

Other disclosures at CME Group

Everything OQRO holds on this company is on its CME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data